Volume 62 Received 14 March 2006 | ||||||||||
| ||||||||||
aDepartment of Chemistry, University of Aberdeen, Meston Walk, Aberdeen AB24 3UE, Scotland, and bDepartment of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India
Correspondence e-mail: w.harrison@abdn.ac.uk
The title compound, C14H10BrFO, possesses normal geometrical parameters. The dihedral angle between the two ring systems is 71.50 (9)°. An unusually short intermolecular Br
Br contact of 3.4311 (5) Å occurs.
The title compound, (I)
, is an intermediate in the synthesis of the antidepressant drug citalopram (Liechti et al., 2000
). More generally, phthalans show distinctive redox chemistry (Azzena et al., 1996
). We have previously deposited (CSD-260624; Cambridge Structural Database; Allen, 2002
) data for a poor quality structure from a twinned crystal of (I)
.
The geometrical parameters for (I)
are normal. Each molecule of (I)
is chiral (the arbitrarily chosen asymmetric unit has an S conformation at C7), but crystal symmetry generates a racemic mixture of the two enantiomers. The nine-membered isobenzofuran ring system (C7-C14/O1) is almost planar [r.m.s. deviation from the mean plane = 0.018 Å; maximum = 0.038 (3) Å for C14] and the dihedral angle between the two ring systems (C7-C14/O1 and C1-C6) is 71.50 (9)°.
A PLATON (Spek, 2003
) analysis of (I)
identified two possible C-H
F interactions (Table 1
) that may help to stabilize the crystal packing (Fig. 2
). There are no significant
-
stacking interactions in (I)
.
Inversion symmetry generates a short intermolecular Br1
Br1i [symmetry code: (i) 2 - x, -y, 1 - z] separation of 3.4311 (5) Å which is significantly less than the van der Waals contact distance of 3.70 Å for two Br atoms (Bondi, 1964
). Some workers have ascribed specific attractive forces to such short intermolecular halogen-halogen contacts (Desiraju & Parthasarathy, 1989
). A database survey of such contacts by Eriksson & Hu (2001
) shows that the present separation lies at the lower end of the observed range of intermolecular Br
Br distances. However, these workers are less certain of the nature of such contacts, and suggest that they may be the consequence - rather than the cause - of the crystal packing.
In the related 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile [i.e. where a cyanide group replaces the Br atom in (I)], there are two molecules in the asymmetric unit with distinctly different degrees of twist between their ring systems (Yathirajan et al., 2004
).
| Figure 1 View of (I) , showing 50% displacement ellipsoids and arbitrary spheres for the H atoms. |
| Figure 2 Unit-cell packing in (I) , viewed down [100], showing 50% displacement ellipsoids and arbitrary spheres for the H atoms, with short C-H F interactions shown as dashed lines. |
5-Bromo-3H-isobenzofuran-1-one (2.13 g, 10 mmol) was subjected to a Grignard reaction with 4-fluorophenyl magnesium bromide (2.4 g, 12 mmol) in tetrahydrofuran (10 ml) at 273 K. The resulting product was treated with sodium borohydride (0.37 g, 10 mmol) in methanol (10 ml) to obtain the diol, which was cyclized with p-toluene sulfonic acid (1 g, 5.81 mmol) in toluene (10 ml) at 353 K, yielding crude (I)
. Diffraction-quality crystals were obtained by recrystallization from n-hexane (Bigler et al., 1977
) (m.p. 318 K).
|
|
| ||||||||||||||||||||||
The H atoms were positioned geometrically, with C-H = 0.95-0.99 Å, and refined as riding, with Uiso(H) = 1.2Ueq(carrier).
Data collection: COLLECT (Nonius, 1998
); cell refinement: SCALEPACK (Otwinowski & Minor, 1997
); data reduction: SCALEPACK and DENZO (Otwinowski & Minor, 1997
), and SORTAV (Blessing, 1995
); program(s) used to solve structure: SHELXS97 (Sheldrick, 1997
); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997
); molecular graphics: ORTEP-3 (Farrugia, 1997
); software used to prepare material for publication: SHELXL97.
We thank the EPSRC National Crystallography Service for data collection. HGA thanks the University of Mysore for provision of research facilities.
Allen, F. H. (2002). Acta Cryst. B58, 380-388. ![[details]](../../../../../../b/graphics/details.gif)
Azzena, U., Demartis, S. & Melloni, G. (1996). J. Org. Chem. 61, 4913-4919.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bigler, A. J., Bogeso, K. B. & Toft, A. (1977). Eur. J. Med. Chem. 12, 289-295. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Blessing, R. H. (1995). Acta Cryst. A51, 33-38. ![[details]](../../../../../../a/graphics/details.gif)
Bondi, A. (1964). J. Phys. Chem. 68, 441-451. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (2003). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Desiraju, G. R. & Parthasarathy, R. (1989). J. Am. Chem. Soc. 111, 8725-8726.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Eriksson, L. & Hu, J. (2001). Acta Cryst. E57, o930-o932. ![[details]](../../../../../../e/graphics/details.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Liechti, M. E., Baumann, C., Gamma, A. & Vollenweider, F. X. (2000). Neuropsychopharmacology, 22, 513-521.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Nonius (1998). COLLECT. Nonius BV, Delft, The Netherlands.
Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Yathirajan, H. S., Nagaraj, B., Gaonkar, S. L., Narasegowda, R. S., Nagaraja, P. & Bolte, M. (2004). Acta Cryst. E60, 2225-2227. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)